Categories: IndustryManufacturingMedtechProductTechnologyCommerceEnergyTechEngineeringFutureHuman
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover and develop novel, high performance enzymes and novel biotherapeutics. Codexis enzymes have applications in the sustainable manufacturing of pharmaceuticals, food, and industrial products; in the creation of the next generation of life science tools; and as gene therapy and biologic therapeutics. The Company’s unique performance enzymes drive improvements such as: reduced energy usage, waste generation and capital requirements; higher yields; higher fidelity diagnostics; and more efficacious therapeutics. Codexis enzymes enable the promise of synthetic biology to improve the health of people and the planet.
Followers
3.72K
Website visits
24.6K /mo.
Mentions
58
Location: United States, California, Redwood City
Employees: 201-500
Total raised: $50M
Founded date: 2002

Investors 2

Funding Rounds 1

DateSeriesAmountInvestors
20.06.2019-$50MCasdin Cap...

Mentions in press and media 58

DateTitleDescriptionSource
28.02.2024Codexis Reports Fourth Quarter and Fiscal Year 2023 Financia...Anticipate 2024 Product Revenue Growth of at Least 10% vs. 2023 Excluding Enzyme Sales Related to PA...einpresswi...
13.02.2024Codexis Secures $40 Million in Strategic Financing Deal with...-globenewsw...
17.11.2022Startup Cradle Lets You Design Custom Proteins By Just Typin...Cradle Team at their site in the Netherlands.Cradleforbes.com...
04.11.2021The SynBio Innovation Accelerator, a Collaboration between C...Funding to accelerate MAI’s go-to-market strategy as the enzyme engineering phase nears completion R...globenewsw...
27.09.2019How To Spot A Synthetic Biology UnicornBiotech is projected to reach $775 billion by 2024, but dozens of companies in the field of ... [+] ...forbes.com...
21.06.2019Codexis Receives $50M Investment from Casdin CapitalCodexis, Inc. (Nasdaq: CDXS), a Redwood City, Calif.-based synthetic biology company, received a $50...finsmes.co...
20.06.2019Codexis Scores $50M REDWOOD CITY, CA, Codexis, a synthetic biology company, has secured $50 million in funding. >&...vcnewsdail...
20.06.2019Eli Cas­din backs Codex­is' plat­form tech with $50M eq­ui­t...About a month af­ter Codex­is notched a deal with No­var­tis $NVS, the Cal­i­for­nia com­pa­ny $CDXS...endpts.com...
13.08.2010Another biofuel IPO: Gevo files for $150M saleWe are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI an...venturebea...
13.08.2010Another biofuel IPO: Gevo files for $150M saleOnly a couple of days after algae-to-fuel company PetroAlgae filed for a $200 million IPO, Gevo — a ...venturebea...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In